BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6296186)

  • 1. Cyproheptadine and mineralocorticoid effector mechanisms.
    Armanini D; Goland GJ; Adam WR; Funder JW
    J Clin Endocrinol Metab; 1983 Feb; 56(2):397-400. PubMed ID: 6296186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia.
    Kuhnle U; Land M; Ulick S
    J Clin Endocrinol Metab; 1986 May; 62(5):934-40. PubMed ID: 3007560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 8. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adrenalectomy and aldosterone on the modulation of mineralocorticoid receptors in rat kidney.
    Claire M; Oblin ME; Steimer JL; Nakane H; Misumi J; Michaud A; Corvol P
    J Biol Chem; 1981 Jan; 256(1):142-7. PubMed ID: 6256342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of mineralocorticoid action of carbenoxolone.
    Armanini D; Karbowiak I; Krozowski Z; Funder JW; Adam WR
    Endocrinology; 1982 Nov; 111(5):1683-6. PubMed ID: 6290195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives.
    Kamata S; Matsui T; Haga N; Nakamura M; Odaguchi K; Itoh T; Shimizu T; Suzuki T; Ishibashi M; Yamada F
    J Med Chem; 1987 Sep; 30(9):1647-58. PubMed ID: 3040999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding and biological activity of 18-oxocortisol.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
    Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproheptadine and mineralocorticoid receptors.
    Armanini D; Karbowiak I; Funder J
    N Engl J Med; 1982 Aug; 307(6):379. PubMed ID: 6283356
    [No Abstract]   [Full Text] [Related]  

  • 15. Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone".
    Krozowski Z; Funder JW
    Endocrinology; 1981 Oct; 109(4):1221-4. PubMed ID: 6269837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the rat kidney mineralocorticoid receptor.
    Eisen LP; Harmon JM
    Endocrinology; 1986 Oct; 119(4):1419-26. PubMed ID: 3019632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone receptor measurements during changes in dietary sodium.
    Grekin RJ; Sider RS
    Endocrinology; 1981 Jan; 108(1):109-12. PubMed ID: 6450676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.
    Rafestin-Oblin ME; Lombes M; Couette B; Baulieu EE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):815-21. PubMed ID: 1314085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 19-Nor progesterone is a mineralocorticoid agonist.
    Funder JW; Adam WR
    Endocrinology; 1981 Jul; 109(1):313-5. PubMed ID: 6263590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of aldosterone receptors in rat kidney: effects of steroid treatment and potassium diet.
    Rafestin-Oblin ME; Claire M; Lombes M; Michaud A; Corvol P
    J Steroid Biochem; 1984 Oct; 21(4):465-70. PubMed ID: 6238210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.